Obeticholic acid

On June 29,Intercept Pharmaceuticals announcedthat it has received a complete new drug application from the US FDA regarding its FXR agonist obeticholic acid (OCA) for fibrosis caused by non-alcoholic steatohepatitis (NASH) Response letter (CRL). The FDA stated in the CRL that based on t

Remdesivir

On October 22, Eastern time,the US FDAofficially approved Gilead’s antiviral Veklury (remdesivir) for use in adults 12 years and older and weighing at least 40 kg in need of hospitalization and COVID-19 treatment. According to the FDA, Veklury is currently the only FDA-approved COVID-19

Approval notice for Rosuvastatin Calcium

Recently, Nantong Chanyoo have made another milestone in the history! With the efforts for more than one year, the first KDMF of Chanyoo has got approved by MFDS. As the biggest manufacturer of Rosuvastatin Calcium in China,we wish to open a new chapter in Korea market.And more products

Registration Certificate (Rosuvastatin)

The difference between Ticagrelor and Clopidogrel

Clopidogrel and Ticagrelor are P2Y12 receptor antagonists that inhibit plateboard adenosine diphosphate (ADP) by selectively inhibiting the binding of adenosine diphosphate (ADP) to its plateboard P2Y12 receptor and the activity of the secondary ADP-mediated glycoprotein GPII.b/III.a complex.Both ar

The difference between atorvastatin calcium tablets and rosuvastatin calcium tablets

Atorvastatin calcium tablets and rosuvastatin calcium tablets are both statin lipid-lowering drugs, and both belong to relatively powerful statin drugs. The specific differences are as follows:1. From the perspective of pharmacodynamics, if the dose is the same, the lipid-lowering effect of rosuvast